News

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...